COVID-19 drug development

From Wikipedia, the free encyclopedia
 
COVID-19 drug development is the research process to develop preventative therapeutic prescription drugs that would alleviate the severity of coronavirus disease 2019 (COVID-19). From early 2020 through 2021, several hundred drug companiesbiotechnology firms, university research groups, and health organizations were developing therapeutic candidates for COVID-19 disease in various stages of preclinical or clinical research (506 total candidates in April 2021), with 419 potential COVID-19 drugs in clinical trials, as of April 2021.[1]
ǁ

Wikipedia editors made it all very clear:  all they sought was to alleviate the severity of the illness.  Thus, a cure for covid was unthinkable.  That explains the weird reaction of media and politicians to the hydroxychloroquine (HCQ) news in March 2020.  

The other factor was  hatred of Trump, but even Trump's own people rejected HCQ after Trump allowed himself to get blindsided by Anthony Fauci, on television.  Trump just folded; had he tried to learn something from the front line doctors, he could have stopped the pandemic in March.  Dr. Zelenko was there, and a few other doctors who were daring, rational, and honest, but Trump let the opportunity slip away.  

So everyone accepted watchful waiting: "We cannot cure covid, go home, take acetaminophen... when your lips turn blue, give us a call."

As early as March 2020, the World Health Organization (WHO),[2] European Medicines Agency (EMA),[3] US Food and Drug Administration (FDA),[4] and the Chinese government and drug manufacturers[5][6] were coordinating with academic and industry researchers to speed development of vaccines, antiviral drugs, and post-infection therapies.[7][8][9][10]

ǁ

Prevention was rejected out of hand.  No vitamin D.  No vitamin C--even though Dr. Fauci himself takes 1-2 grams of Vitamin C and 4000 IU of vitamin D.  No zinc.  No interest in elderberries. nigella, quesrcetin.  

Coincidences? All the cheap methods were turned down; only expensive and ineffective methods were chosen, starting with remdesivir, ending with monoclonal antibodies--which have been added to acetaminophen as official allowed treatment in the U.S. 

Greed is a proposed explanation for the fact that, now that the vaccine's star is sinking, an expensive and dangerous antiviral is being trundled out, molnupiravir.  At $700 per course of 5 days, the US government has already paid 1 billion dollars to Merck.  They created ivermectin but they do not like it, it's too cheap.  

Besides greed, could there be another explanation, for the media refusal to present the doctors who, in different countries, have offered different solutions for covid, since February 2020?